SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a source of pain in 15% to 30% of chronic low back pain. The iFuse Implant™, commercially available since 2009, is the only SI joint fusion device supported by multiple prospective clinical studies, including two randomized controlled trials, showing improved pain, patient function and quality of life resulting from treatment. There are over 90 peer-reviewed publications demonstrating the safety, durable effectiveness, and biomechanical and economic benefits unique to the iFuse Implant (www.si-bone.com/results). This body of evidence has enabled multiple government and private insurance payors to establish coverage of the SI joint fusion procedure exclusively when performed with the iFuse Implant System.
471 El Camino Real Ste 101
Santa Clara, California 95050-4482
Phone: 14082070700
si-bone.com
SI-BONE to present at Canaccord Genuity Growth Conference. Learn about their sacropelvic disorder treatments and growth strategies. Join the fireside chat on Aug 14, 2024, or access the webcast for key investor insights.
SI-BONE, Inc. (NASDAQ:NASDAQ:SIBN) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ETCompany ParticipantsSaqib Iqbal - Senior Director of Investor…
SANTA CLARA, Calif. (AP) — SANTA CLARA, Calif. (AP) — Si-Bone Inc. (SIBN) on Monday reported a loss of $8.9 million in its second quarter.
SI-Bone (SIBN) has shared an announcement. Daniel Wolf has been elected as a director of the Company by its board, starting from August 5, 2024. He…
SI-BONE reports robust Q2 2024 results: 20% revenue growth, improved net loss, and increased 2024 guidance. Discover key financial highlights and operational achievements driving the company''s positive outlook.
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the second quarter of 2024 after market close on Monday, August 5, 2024. Management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
